The therapeutic role of ivabradine in heart failure

about

The therapeutic role of ivabradine in heart failure

Item

http://www.wikidata.org/entity/Q58568726

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

The therapeutic role of ivabradine in heart failure

@en

The therapeutic role of ivabradine in heart failure

@nl

type

Item

label

The therapeutic role of ivabradine in heart failure

@en

The therapeutic role of ivabradine in heart failure

@nl

prefLabel

The therapeutic role of ivabradine in heart failure

@en

The therapeutic role of ivabradine in heart failure

@nl

P1476

The therapeutic role of ivabradine in heart failure

@en

P2093

Charles Badu-Boateng

http://www.w3.org/2001/XMLSchema#string

Daniel Hammersley

http://www.w3.org/2001/XMLSchema#string

Robert Jennings

http://www.w3.org/2001/XMLSchema#string

P2860

The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 Patients

Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.

Funny channels in the control of cardiac rhythm and mode of action of selective blockers.

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society o

Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study.

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.

P304

199-207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2040622318784556

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30364460

http://www.w3.org/2001/XMLSchema#string

P932

6196638

http://www.w3.org/2001/XMLSchema#string